“Finding a data-driven way to structure those experiences to maximize therapeutic benefit, I think is something we can all get excited about,” says Sam Freesun Friedman, a senior machine learning scientist at Massachusetts Institute of Technology and Harvard University’s Broad Institute. An exciting new neuroscience study powered by AI aims to better understand the interaction between hallucinogenic drugs, people’s brains, and different types of psychedelic experiences. Read more via Popular Science #psychedelicscience # psilocybin # psychedelicresearch # psychedelicmedicine #research